Advances in vaccine technologies and trials are leading to robust data for global vaccination efforts. Current vaccines have varying degrees of efficacy, and emerging variants are creating further deviation, suggesting a need for a rapid increase in vaccinations as well as improved molecular surveillance.
Data demonstrate potential for monoclonal antibodies in treatment and prevention of COVID-19 in select patients. Emergence of variants may affect current and future utility and will necessitate discernment from healthcare professionals.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.